Ennov Successfully Completes eCTD 4.0 Submission to EMA, Giving Customers a Head Start - Journal of Cyber Policy

Ennov eCTD4.0 Ennov is one of four providers to successfully complete an eCTD 4.0 test submission to the EMA, giving customers a clear advantage. Our customers are ready for eCTD 4.0 – with no surprises. They know they can rely on Ennov.” — Diarmuid Waide, Senior RIM Consultant at Ennov. PARIS, FRANCE, May 26, 2025 /EINPresswire.com/ — Ennov, a global provider of a unified regulatory platform for life sciences, has successfully completed an eCTD…

PARIS, FRANCE, May 26, 2025 /EINPresswire.com/ -- Ennov, a global provider of a unified regulatory platform for life sciences, has successfully completed an eCTD 4.0 test submission to the European Medicines Agency (EMA). As one of four vendors to reach this milestone, Ennov's submission was accepted, uploaded to the EMA system, and reviewed by the EMA without any issues: proof of full compatibility. A big win for all customers in their eCTD 4.0…